{"id":12483,"date":"2026-05-05T10:03:55","date_gmt":"2026-05-05T13:03:55","guid":{"rendered":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/?p=12483"},"modified":"2026-05-05T10:08:41","modified_gmt":"2026-05-05T13:08:41","slug":"canetas-emagrecedoras-e-interacao-com-medicamentos","status":"publish","type":"post","link":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/canetas-emagrecedoras-e-interacao-com-medicamentos\/","title":{"rendered":"Canetas Emagrecedoras e Intera\u00e7\u00e3o com Outros Medicamentos: O que devemos Saber?"},"content":{"rendered":"<h1><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-12485\" src=\"http:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-chatgpt-image-5-de-mai.-de-2026-09-54-14.jpg\" alt=\"\" width=\"683\" height=\"455\" srcset=\"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-chatgpt-image-5-de-mai.-de-2026-09-54-14.jpg 1200w, https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-chatgpt-image-5-de-mai.-de-2026-09-54-14-300x200.jpg 300w, https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-chatgpt-image-5-de-mai.-de-2026-09-54-14-1024x683.jpg 1024w, https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-chatgpt-image-5-de-mai.-de-2026-09-54-14-768x512.jpg 768w\" sizes=\"(max-width: 683px) 100vw, 683px\" \/><\/h1>\n<h1>Os medicamentos que imitam a a\u00e7\u00e3o do horm\u00f4nio GLP-1 t\u00eam sido cada vez mais usados no tratamento do diabetes e da obesidade.<\/h1>\n<p>Eles atuam de v\u00e1rias formas no organismo:<\/p>\n<ul>\n<li>ajudam a retardar o esvaziamento do est\u00f4mago (fazendo a pessoa se sentir saciada por mais tempo)<\/li>\n<li>reduzem a libera\u00e7\u00e3o de glucagon (um horm\u00f4nio que aumenta o a\u00e7\u00facar no sangue)<\/li>\n<li>promovem altera\u00e7\u00f5es positivas na flora intestinal<\/li>\n<li>tamb\u00e9m agem diretamente no c\u00e9rebro, especialmente em \u00e1reas que controlam a fome e a saciedade<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-12486\" src=\"http:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-tirze.jpg\" alt=\"\" width=\"573\" height=\"683\" srcset=\"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-tirze.jpg 1007w, https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-tirze-252x300.jpg 252w, https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-tirze-859x1024.jpg 859w, https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-content\/uploads\/2026\/05\/robertofrancodoamaral.com.br-canetas-emagrecedoras-e-interacao-com-outros-medicamentos-o-que-devemos-saber-tirze-768x915.jpg 768w\" sizes=\"(max-width: 573px) 100vw, 573px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p data-start=\"0\" data-end=\"332\">Os medicamentos que imitam o GLP-1 costumam ter poucas intera\u00e7\u00f5es importantes com outros rem\u00e9dios quando pensamos em metabolismo.<\/p>\n<p data-start=\"0\" data-end=\"332\">,O principal ponto de aten\u00e7\u00e3o \u00e9 outro: eles deixam o esvaziamento do est\u00f4mago mais lento. Isso pode atrasar a absor\u00e7\u00e3o de medicamentos tomados por via oral e fazer com que demorem mais para fazer efeito.<\/p>\n<p data-start=\"334\" data-end=\"378\"><strong>Algumas intera\u00e7\u00f5es merecem aten\u00e7\u00e3o especial:<\/strong><\/p>\n<ul data-start=\"380\" data-end=\"1101\">\n<li data-section-id=\"uj0twz\" data-start=\"380\" data-end=\"538\"><strong data-start=\"382\" data-end=\"410\">Anticoncepcionais orais:<\/strong> alguns estudos, especialmente com a tirzepatida, mostram que pode haver altera\u00e7\u00e3o na absor\u00e7\u00e3o, o que pode reduzir a efic\u00e1cia.\u00a0 Recomenda-se efeito adicional tempor\u00e1rio<\/li>\n<li data-section-id=\"16a315i\" data-start=\"539\" data-end=\"675\"><strong data-start=\"541\" data-end=\"558\">Levotiroxina:<\/strong> a forma oral da semaglutida pode modificar a absor\u00e7\u00e3o desse horm\u00f4nio da tireoide, exigindo ajuste e monitoramento. A <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Semaglutida oral<\/span><\/span> pode interferir na absor\u00e7\u00e3o da <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Levotiroxina<\/span><\/span>.<\/li>\n<li data-section-id=\"zf732o\" data-start=\"676\" data-end=\"851\"><strong data-start=\"678\" data-end=\"708\">Insulina e sulfonilureias (<\/strong><span class=\"T286Pc\" data-sfc-cp=\"\" data-sfc-root=\"c\" data-sfc-cb=\"\" data-copy-service-computed-style=\"font-family: &quot;Google Sans&quot;, Arial, sans-serif; font-size: 16px; font-weight: 400; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);\">Glibenclamida, <\/span><span class=\"T286Pc\" data-sfc-cp=\"\" data-sfc-root=\"c\" data-sfc-cb=\"\" data-copy-service-computed-style=\"font-family: &quot;Google Sans&quot;, Arial, sans-serif; font-size: 16px; font-weight: 400; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);\">Gliclazida, <\/span><span class=\"T286Pc\" data-sfc-cp=\"\" data-sfc-root=\"c\" data-sfc-cb=\"\" data-copy-service-computed-style=\"font-family: &quot;Google Sans&quot;, Arial, sans-serif; font-size: 16px; font-weight: 400; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);\">Glimepirida, <\/span><span class=\"T286Pc\" data-sfc-cp=\"\" data-sfc-root=\"c\" data-sfc-cb=\"\" data-copy-service-computed-style=\"font-family: &quot;Google Sans&quot;, Arial, sans-serif; font-size: 16px; font-weight: 400; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);\">Glipizida)\u00a0 <\/span>quando usados juntos, aumentam o risco de hipoglicemia (queda do a\u00e7\u00facar no sangue), sendo comum precisar reduzir a dose desses medicamentos.<\/li>\n<li data-section-id=\"1ap44n4\" data-start=\"852\" data-end=\"1000\"><strong data-start=\"854\" data-end=\"878\">Inibidores da DPP-4 como <\/strong><span class=\"T286Pc\" data-sfc-cp=\"\" data-sfc-root=\"c\" data-sfc-cb=\"\" data-copy-service-computed-style=\"font-family: &quot;Google Sans&quot;, Arial, sans-serif; font-size: 16px; font-weight: 400; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);\">Sitagliptina (Januvia\u00ae),<\/span><span class=\"T286Pc\" data-sfc-cp=\"\" data-sfc-root=\"c\" data-sfc-cb=\"\" data-copy-service-computed-style=\"font-family: &quot;Google Sans&quot;, Arial, sans-serif; font-size: 16px; font-weight: 400; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);\">Vildagliptina (Galvus\u00ae), <\/span><span class=\"T286Pc\" data-sfc-cp=\"\" data-sfc-root=\"c\" data-sfc-cb=\"\" data-copy-service-computed-style=\"font-family: &quot;Google Sans&quot;, Arial, sans-serif; font-size: 16px; font-weight: 400; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);\">Saxagliptina (Onglyza\u00ae): <\/span>\u00a0n\u00e3o devem ser usados junto com agonistas de GLP-1, pois atuam na mesma via e n\u00e3o h\u00e1 benef\u00edcio comprovado na combina\u00e7\u00e3o.<\/li>\n<li data-section-id=\"1e69j19\" data-start=\"1001\" data-end=\"1101\"><strong data-start=\"1003\" data-end=\"1019\">Dabigatrana ( anti -coagulante) :<\/strong> pode ter aumento importante na absor\u00e7\u00e3o, o que eleva o risco de efeitos adversos.<\/li>\n<\/ul>\n<p data-start=\"1103\" data-end=\"1411\" data-is-last-node=\"\" data-is-only-node=\"\">Por outro lado, esses medicamentos n\u00e3o costumam interferir de forma relevante com v\u00e1rios rem\u00e9dios comuns, como varfarina, digoxina, lisinopril, metformina, atorvastatina e paracetamol \u2014 embora possam ocorrer pequenas mudan\u00e7as na velocidade de absor\u00e7\u00e3o, sem impacto cl\u00ednico significativo na maioria dos casos.<\/p>\n<p data-start=\"1103\" data-end=\"1411\" data-is-last-node=\"\" data-is-only-node=\"\">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p data-start=\"1103\" data-end=\"1411\" data-is-last-node=\"\" data-is-only-node=\"\"><strong>REFER\u00caNCIAS:\u00a0<\/strong><\/p>\n<ul data-start=\"3105\" data-end=\"3197\">\n<li data-section-id=\"xzw039\" data-start=\"3105\" data-end=\"3197\">\n<p data-start=\"4107\" data-end=\"4294\">BLUNDELL, J. et al. Effects of GLP-1 receptor agonists on appetite and body weight. <em data-start=\"4191\" data-end=\"4225\">International Journal of Obesity<\/em>, 2017. Dispon\u00edvel em:<br data-start=\"4247\" data-end=\"4250\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28264089\/\" target=\"_new\" rel=\"noopener\" data-start=\"4253\" data-end=\"4294\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28264089\/<\/a><\/p>\n<p data-start=\"4296\" data-end=\"4473\">BUSE, J. B. et al. Safety and tolerability of GLP-1 receptor agonists. <em data-start=\"4367\" data-end=\"4404\">The Lancet Diabetes &amp; Endocrinology<\/em>, 2019. Dispon\u00edvel em:<br data-start=\"4426\" data-end=\"4429\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30857963\/\" target=\"_new\" rel=\"noopener\" data-start=\"4432\" data-end=\"4473\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30857963\/<\/a><\/p>\n<p data-start=\"4475\" data-end=\"4664\">FOOD AND DRUG ADMINISTRATION (FDA). Tirzepatide Clinical Pharmacology Review, 2022. Dispon\u00edvel em:<br data-start=\"4573\" data-end=\"4576\" \/><a class=\"decorated-link\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2022\/215866Orig1s000ClinPharmR.pdf\" target=\"_new\" rel=\"noopener\" data-start=\"4579\" data-end=\"4664\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2022\/215866Orig1s000ClinPharmR.pdf<\/a><\/p>\n<p data-start=\"4666\" data-end=\"4844\">GRANHALL, C. et al. Effect of oral semaglutide on levothyroxine pharmacokinetics. <em data-start=\"4748\" data-end=\"4775\">Clinical Pharmacokinetics<\/em>, 2019. Dispon\u00edvel em:<br data-start=\"4797\" data-end=\"4800\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30891886\/\" target=\"_new\" rel=\"noopener\" data-start=\"4803\" data-end=\"4844\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30891886\/<\/a><\/p>\n<p data-start=\"4846\" data-end=\"4994\">HOLST, J. J. The physiology of glucagon-like peptide-1. <em data-start=\"4902\" data-end=\"4925\">Physiological Reviews<\/em>, 2007. Dispon\u00edvel em:<br data-start=\"4947\" data-end=\"4950\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17329546\/\" target=\"_new\" rel=\"noopener\" data-start=\"4953\" data-end=\"4994\">https:\/\/pubmed.ncbi.nlm.nih.gov\/17329546\/<\/a><\/p>\n<p data-start=\"4996\" data-end=\"5144\">NAUCK, M. A. et al. Incretin-based therapies: how do they work? <em data-start=\"5060\" data-end=\"5075\">Diabetes Care<\/em>, 2009. Dispon\u00edvel em:<br data-start=\"5097\" data-end=\"5100\" \/><a class=\"decorated-link cursor-pointer\" target=\"_new\" rel=\"noopener\" data-start=\"5103\" data-end=\"5144\">https:\/\/pubmed.ncbi.nlm.nih.gov\/19109216\/<\/a><\/p>\n<p data-start=\"5146\" data-end=\"5328\">WANG, Y. et al. GLP-1 receptor agonists and gut microbiota. <em data-start=\"5206\" data-end=\"5234\">Frontiers in Endocrinology<\/em>, 2020. Dispon\u00edvel em:<br data-start=\"5256\" data-end=\"5259\" \/><a class=\"decorated-link\" href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.00570\/full\" target=\"_new\" rel=\"noopener\" data-start=\"5262\" data-end=\"5328\">https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.00570\/full<\/a><\/p>\n<p data-start=\"5330\" data-end=\"5468\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">American Diabetes Association<\/span><\/span>. Standards of Care in Diabetes \u2013 2024. Dispon\u00edvel em:<br data-start=\"5423\" data-end=\"5426\" \/><a class=\"decorated-link\" href=\"https:\/\/diabetesjournals.org\/care\/issue\" target=\"_new\" rel=\"noopener\" data-start=\"5429\" data-end=\"5468\">https:\/\/diabetesjournals.org\/care\/issue<\/a><\/p>\n<p data-start=\"5470\" data-end=\"5591\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">European Medicines Agency<\/span><\/span>. Drug interaction reports, 2023. Dispon\u00edvel em:<br data-start=\"5557\" data-end=\"5560\" \/><a class=\"decorated-link\" href=\"https:\/\/www.ema.europa.eu\/en\" target=\"_new\" rel=\"noopener\" data-start=\"5563\" data-end=\"5591\">https:\/\/www.ema.europa.eu\/en<\/a><\/p>\n<\/li>\n<li data-section-id=\"xzw039\" data-start=\"3105\" data-end=\"3197\">: Agonistas do receptor GLP-1 e intera\u00e7\u00f5es medicamentosas: o que a evid\u00eancia dispon\u00edvel revela &#8211; Medscape &#8211; 27 de abril de 2026.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Os medicamentos que imitam a a\u00e7\u00e3o do horm\u00f4nio GLP-1 t\u00eam sido cada vez mais usados no tratamento do diabetes e da obesidade. Eles atuam de v\u00e1rias formas no organismo: ajudam a retardar o esvaziamento do est\u00f4mago (fazendo a pessoa se sentir saciada por mais tempo) reduzem a libera\u00e7\u00e3o de glucagon (um horm\u00f4nio que aumenta o [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":12485,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[6],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/posts\/12483"}],"collection":[{"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/comments?post=12483"}],"version-history":[{"count":2,"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/posts\/12483\/revisions"}],"predecessor-version":[{"id":12488,"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/posts\/12483\/revisions\/12488"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/media\/12485"}],"wp:attachment":[{"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/media?parent=12483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/categories?post=12483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.robertofrancodoamaral.com.br\/blog\/wp-json\/wp\/v2\/tags?post=12483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}